Related Experiment Video
Updated: Jul 11, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Changing epidemiology of Clostridium difficile-associated disease in children
Lacey Benson1, Xiaoyan Song, Joseph Campos
1Case Western School of Medicine, Cleveland, OH, USA.
Insights
Pediatric Clostridium difficile-associated disease (CDAD) incidence rose in emergency departments, particularly community-associated CDAD, while inpatient cases declined. This suggests changing disease characteristics in children, a previously low-risk group.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Microbiology
Background:
- Clostridium difficile-associated disease (CDAD) is a significant healthcare-associated infection.
- While historically considered low-risk, pediatric populations may be experiencing shifts in CDAD incidence and characteristics.
- Understanding temporal trends in pediatric CDAD is crucial for public health and clinical management.
Purpose of the Study:
- To investigate the temporal trends in the incidence rate of Clostridium difficile-associated disease (CDAD) within a pediatric patient population.
- To analyze changes in CDAD rates across different healthcare settings (inpatient, outpatient, emergency department, NICU) over a five-year period.
Main Methods:
- An observational, retrospective cohort study was conducted.
- Data were collected from pediatric patients at Children's National Medical Center between July 2001 and June 2006.
- Poisson regression analysis was used to assess temporal trends in CDAD incidence rates.
Main Results:
- A total of 513 pediatric patients tested positive for C. difficile toxin.
- The incidence of community-associated CDAD significantly increased in the emergency department (1.18 to 2.47 cases per 1,000 visits, P=.02).
- Conversely, inpatient CDAD incidence decreased (1.024 to 0.680 cases per 1,000 patient-days, P=.004).
- CDAD was also detected in 22 neonates in the NICU.
Conclusions:
- A notable increase in community-acquired CDAD was observed in pediatric emergency department visits.
- The findings indicate evolving patterns of CDAD in children, challenging previous assumptions about their low-risk status.
- Further research is needed to understand these changing disease burdens and identify specific risk factors in pediatric populations.
Objective:
To determine temporal trends in the incidence rate for Clostridium difficile-associated disease (CDAD) in a pediatric patient population.
Methods:
We performed an observational, retrospective cohort study that included children who visited or were admitted to Children's National Medical Center during the period from July 2001 through June 2006. The CDAD incidence rates were determined and examined for changes over time using the Poisson regression method.
Results:
A total of 513 patients whose stool specimens tested positive for C. difficile toxin were identified. Of these patients, 61% were children aged 2 years or older. The proportion of patients with CDAD in this age group has steadily increased from 46% in 2001 to 64% in 2006. Largely as a result of an increasing number of cases of community-associated CDAD, the incidence of CDAD increased significantly in the outpatient setting, particularly in the emergency department (1.18 cases per 1,000 visits in 2001 vs 2.47 cases per 1,000 visits in 2006; P=.02). The incidence among inpatients decreased during the study period (1.024 cases per 1,000 patient-days in 2001 vs 0.680 cases per 1,000 patient-days in 2006; P=.004). In the neonatal intensive care unit, C. difficile toxin was detected in stool specimens collected from 22 patients aged from 15 days to 6 months.
Conclusion:
This study revealed a steady increase in the number of patients seen in the emergency department with community-acquired CDAD. Findings from this study suggest that the characteristics of CDAD in children--a population that has not been considered to be at high risk for this disease in the past--are changing. Further investigations are warranted to explore deviations from the established burdens of the disease and patient risk factors.
Related Concept Videos
Bacterial Gastroenteritis
Development of Human Microbiota
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease III: Crohn's Disease
Investigation of Disease Outbreaks
